# Zilretta

NDC: 65250-003
Generic name: triamcinolone acetonide extended-release injectable suspension
Labeler / Manufacturer: Pacira Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: KIT
Routes: INTRA-ARTICULAR
Marketing started: 20171006

FDA application: NDA208845

## Active ingredients

—

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"65250-003"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=65250-003
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cd5c4673-21f2-4126-9556-da847b3a228b